Medications Contraindicated in Children with G6PD Deficiency
Primaquine is absolutely contraindicated in children with G6PD deficiency due to the risk of severe, life-threatening hemolytic anemia 1. Beyond primaquine, only a small number of medications have solid evidence for prohibition in G6PD-deficient children.
High-Risk Medications to Avoid
Based on the strongest available evidence, the following medications should be strictly avoided in children with G6PD deficiency:
Definitively Contraindicated:
- Primaquine - causes severe hemolysis; G6PD testing must be performed before use 1, 2
- Dapsone - associated with hemolytic risk 3, 4
- Rasburicase - high risk for hemolysis 3, 4, 5
- Methylthioninium chloride (methylene blue) - causes hemolysis 3, 4
- Nitrofurantoin - documented hemolytic risk 3, 4
- Phenazopyridine - can trigger hemolysis 3, 4
Important Clinical Considerations
Primaquine-Specific Guidance:
In populations where severe G6PD deficiency is common (notably among Asians with the Mediterranean B- variant), primaquine should not be administered for greater than 5 days as longer periods may result in life-threatening hemolysis 6. The African variant (A-) has milder deficiency and is relatively resistant to severe primaquine-induced hemolysis 7.
Common Pitfalls to Avoid:
Many medications are incorrectly labeled as dangerous for G6PD-deficient patients. A comprehensive evidence-based review found that numerous compounds have been wrongly cited as causing hemolysis because they were administered during infection-related hemolytic episodes, not because the drug itself caused hemolysis 3.
Medications That Are Actually SAFE:
Real-world data from over 31,000 G6PD-deficient patients demonstrated safe use of:
- Nitrofurantoin (prescribed safely to 1,366 patients)
- Ciprofloxacin and ofloxacin
- Sulfamethoxazole/cotrimoxazole
- Sulfasalazine
- Hydroxychloroquine
- Phenazopyridine (despite theoretical concerns) 8
Chloroquine is explicitly safe in G6PD-deficient children and can be used for malaria treatment at standard doses 6.
Practical Algorithm for Medication Use:
Before prescribing any antimalarial or oxidative medication: Verify G6PD status through laboratory testing 1
If G6PD deficiency confirmed:
- Absolutely avoid: primaquine (except ≤5 days in African variant), dapsone, rasburicase, methylene blue, nitrofurantoin, phenazopyridine
- Safe to use: chloroquine, most antibiotics, most common medications
For malaria treatment in G6PD-deficient children:
- Use chloroquine as first-line (25 mg/kg total over 3 days) 6
- Avoid primaquine for radical cure unless African variant AND limited to 5 days maximum
- Alternative antimalarials (artemisinin combinations, mefloquine) can be used
Monitor for hemolysis signs: jaundice, dark urine, back/abdominal pain, sudden anemia 4
Critical Safety Point:
The majority of hemolytic crises in G6PD-deficient patients are triggered by infections (71.8% in one large study) or fava bean ingestion, NOT medications 8. Only 4.2% of major hemolytic episodes were medication-related in a real-world cohort of nearly 32,000 patients.
Age-specific considerations: Doxycycline is contraindicated in children <8 years (due to dental effects, not G6PD) 1. Mefloquine is not indicated for children <15 kg 1.